Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study - Concepedia

Concepedia

Publication | Closed Access

Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study

386

Citations

20

References

2014

Year

Peter A. Calabresi, Bernd C Kieseier, Douglas L. Arnold, Laura J. Balcer, Jean Pelletier, Shifang Liu, Ying Zhu, Ali Seddighzadeh, Serena Hung, Aaron Deykin

The Lancet Neurology

Relapsing-remitting Multiple SclerosisAutoimmune DiseaseNeurological DisorderImmunologyClinical TrialsNeurologyInterferon Beta-1aMultiple SclerosisTherapeuticsMedicineNovel TherapyPhase 3

References

	Year	Citations

Page 1

Page 1